XKRX214680
Market cap104mUSD
Jan 09, Last price
2,385.00KRW
1D
-0.63%
1Q
-22.82%
Jan 2017
10.16%
IPO
1.71%
Name
DR Tech Corp
Chart & Performance
P/E
—
P/S
1.64
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
6.90%
Revenues
92.44b
+3.31%
Net income
-2.25b
L
CFO
-7.94b
L
Profile
DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, and AI CAD; and radiography, mammography, and C-arm systems. DRTECH Corporation was founded in 2000 and is headquartered in Seongnam-si, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 92,438,893 3.31% | 89,481,004 27.33% | |||
Cost of revenue | 72,874,896 | 69,729,809 | |||
Unusual Expense (Income) | |||||
NOPBT | 19,563,998 | 19,751,195 | |||
NOPBT Margin | 21.16% | 22.07% | |||
Operating Taxes | 1,210,407 | (722,132) | |||
Tax Rate | 6.19% | ||||
NOPAT | 18,353,591 | 20,473,327 | |||
Net income | (2,248,436) -137.65% | 5,972,058 47.89% | |||
Dividends | (500) | ||||
Dividend yield | 0.00% | ||||
Proceeds from repurchase of equity | 939,251 | 8,572,367 | |||
BB yield | -0.33% | -9.95% | |||
| Debt | |||||
Debt current | 22,095,564 | 35,008,789 | |||
Long-term debt | 61,498,358 | 11,237,719 | |||
Deferred revenue | (24,712) | 1,191,009 | |||
Other long-term liabilities | 11,697,836 | 3,543,393 | |||
Net debt | 59,432,303 | 25,055,999 | |||
| Cash flow | |||||
Cash from operating activities | (7,936,573) | 5,037,706 | |||
CAPEX | (9,956,905) | (7,796,435) | |||
Cash from investing activities | (15,478,919) | (11,900,521) | |||
Cash from financing activities | 21,857,156 | 10,098,068 | |||
FCF | (27,575,631) | 11,309,786 | |||
| Balance | |||||
Cash | 24,407,110 | 22,087,473 | |||
Long term investments | (245,492) | (896,965) | |||
Excess cash | 19,539,674 | 16,716,458 | |||
Stockholders' equity | 7,630,311 | 9,471,331 | |||
Invested Capital | 146,363,337 | 94,179,814 | |||
ROIC | 15.26% | 23.70% | |||
ROCE | 12.70% | 19.04% | |||
| EV | |||||
Common stock shares outstanding | 66,130 | 62,209 | |||
Price | 4,260.00 207.58% | 1,385.00 -20.86% | |||
Market cap | 281,715,747 226.97% | 86,159,383 -31.72% | |||
EV | 341,673,872 | 111,178,537 | |||
EBITDA | 27,543,090 | 26,254,695 | |||
EV/EBITDA | 12.41 | 4.23 | |||
Interest | 1,976,863 | 1,359,444 | |||
Interest/NOPBT | 10.10% | 6.88% | |||